Meeder Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-12,701
| Closed | -$97K | – | 2510 |
|
|
2021
Q3 | $97K | Buy |
12,701
+335
| +3% | +$2.56K | 0.01% | 904 |
|
|
2021
Q2 | $120K | Buy |
12,366
+5,776
| +88% | +$56.1K | 0.01% | 855 |
|
|
2021
Q1 | $55K | Buy |
+6,590
| New | +$55K | ﹤0.01% | 1076 |
|
|
2020
Q4 | – | Sell |
-8,031
| Closed | -$90K | – | 2346 |
|
|
2020
Q3 | $90K | Buy |
8,031
+646
| +9% | +$7.24K | 0.01% | 814 |
|
|
2020
Q2 | $46K | Buy |
7,385
+6,762
| +1,085% | +$42.1K | ﹤0.01% | 944 |
|
|
2020
Q1 | $1K | Buy |
+623
| New | +$1K | ﹤0.01% | 2262 |
|
|
2019
Q2 | – | Sell |
-780
| Closed | -$4K | – | 2187 |
|
|
2019
Q1 | $4K | Buy |
+780
| New | +$4K | ﹤0.01% | 1463 |
|
|
2018
Q4 | – | Sell |
-4,063
| Closed | -$17K | – | 1848 |
|
|
2018
Q3 | $17K | Buy |
+4,063
| New | +$17K | ﹤0.01% | 1068 |
|
|
2018
Q2 | – | Sell |
-223
| Closed | -$1K | – | 1718 |
|
|
2018
Q1 | $1K | Sell |
223
-1,084
| -83% | -$4.86K | ﹤0.01% | 1502 |
|
|
2017
Q4 | $5K | Sell |
1,307
-610
| -32% | -$2.33K | ﹤0.01% | 1334 |
|
|
2017
Q3 | $3K | Buy |
1,917
+1,049
| +121% | +$1.64K | ﹤0.01% | 1406 |
|
|
2017
Q2 | $2K | Hold |
868
| – | – | ﹤0.01% | 1450 |
|
|
2017
Q1 | $3K | Buy |
868
+62
| +8% | +$214 | ﹤0.01% | 1294 |
|
|
2016
Q4 | $4K | Buy |
+806
| New | +$4K | ﹤0.01% | 888 |
|